{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "exchange": "FRA", "shortName": "ORPHAZYME A/S  DK 1", "longName": "Orphazyme A/S", "messageBoardId": "finmb_99715906", "market": "dr_market", "marketState": "REGULAR", "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -2.38, "sharesOutstanding": 35312200, "bookValue": 1.181, "fiftyDayAverage": 0.10409, "fiftyDayAverageChange": 0.034110002, "fiftyDayAverageChangePercent": 0.32769722, "twoHundredDayAverage": 0.136778, "tradeable": false, "cryptoTradeable": false, "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "esgPopulated": false, "regularMarketChangePercent": -0.71839225, "regularMarketPrice": 0.1382, "regularMarketChange": -0.001000002, "regularMarketTime": 1683871385, "regularMarketDayHigh": 0.1382, "regularMarketDayRange": "0.1382 - 0.1382", "regularMarketDayLow": 0.1382, "regularMarketVolume": 200, "regularMarketPreviousClose": 0.1392, "bid": 0.151, "ask": 0.1704, "bidSize": 700, "askSize": 700, "fullExchangeName": "Frankfurt", "financialCurrency": "DKK", "regularMarketOpen": 0.1382, "averageDailyVolume3Month": 11, "averageDailyVolume10Day": 0, "fiftyTwoWeekLowChange": 0.053400002, "fiftyTwoWeekLowChangePercent": 0.62971705, "fiftyTwoWeekRange": "0.0848 - 0.3176", "fiftyTwoWeekHighChange": -0.17940001, "fiftyTwoWeekHighChangePercent": -0.5648615, "fiftyTwoWeekLow": 0.0848, "fiftyTwoWeekHigh": 0.3176, "twoHundredDayAverageChange": 0.0014220029, "twoHundredDayAverageChangePercent": 0.01039643, "marketCap": 4880146, "priceToBook": 0.117019475, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "firstTradeDateMilliseconds": 1551855600000, "priceHint": 4, "symbol": "1TB.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Ole Maal\u00f8es Vej 3", "city": "Copenhagen", "zip": "2200", "country": "Denmark", "phone": "45 70 70 29 80", "website": "https://www.orphazyme.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Orphazyme A/S does not have significant operations. Previously, the company was engaged in the development of therapies for the treatment of neurodegenerative rare diseases. The company was incorporated in 2009 and is headquartered in Copenhagen, Denmark.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Anders Fink Vadsholt M.B.A., M.Sc., MBA", "age": 53, "title": "CEO, CFO & Director", "yearBorn": 1969, "fiscalYear": 2022, "totalPay": {"raw": 1117237, "fmt": "1.12M", "longFmt": "1,117,237"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Jennifer Jean McCann", "title": "Pres of Orphazyme US, Inc.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}